ENANTA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 827 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 401-425 of 826 matching filings.

Per page
25
Current page
17
DEF 14A File 001-35839

DEF 14A

Filing date
17 Jan 2020
Reporting date
26 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2020
Reporting date
16 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2020
Reporting date
16 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2020
Reporting date
16 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2020
Reporting date
16 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2020
Reporting date
16 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Nov 2019
Reporting date
22 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
25 Nov 2019
Reporting date
26 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K Q4 2019 EARNINGS RELEASE

Filing date
21 Nov 2019
Reporting date
21 Nov 2019
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Oct 2019
Reporting date
08 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Sep 2019
Reporting date
27 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87373

SC 13G filing

Filing date
27 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35839

Q3 2019 10-Q

Filing date
09 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
8-K File 001-35839

Q3 2019 EARNINGS RELEASE 8-K

Filing date
06 Aug 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Jun 2019
Reporting date
26 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-231384

S-8 - 2019 AND 2012 EQUITY INCENTIVE PLANS

Filing date
10 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-231375

S-8 2012 EQUITY INCENTIVE PLAN

Filing date
10 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35839

Q2 2019 10-Q - MARCH 31, 2019

Filing date
10 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
8-K File 001-35839

Q2 2019 8-K

Filing date
07 May 2019
Reporting date
07 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .